PNMA1 is a domesticated retrotransposon-derived capsid gene with dual roles in reproduction and cancer progression. Primary function: PNMA1 maintains reproductive capacity through a germ cell-specific regulatory mechanism 1. The protein self-assembles into capsid-like structures that exit cells and decline with age; PNMA1 variants associate with altered testosterone, puberty onset, and obesity 2. In mouse models, Pnma1 knockout causes premature subfertility by six months with gonadal atrophy and reduced offspring 3. Mechanism in cancer: PNMA1 promotes tumorigenesis across multiple cancer types via pathway activation and immune suppression. In pancreatic ductal adenocarcinoma, PNMA1 elevates expression activates PI3K/AKT and MAPK/ERK signaling while promoting anti-apoptotic Bcl-2 family activity 4. In hepatocellular carcinoma, PNMA1 overexpression creates an immunosuppressive tumor microenvironment linked to bile acid metabolism and activates PI3K/AKT signaling; miR-33a-5p provides posttranscriptional regulation 56. In retinoblastoma, PNMA1 mediates melphalan chemoresistance through c-myc-dependent DNA damage repair pathway activation 7. Clinical significance: High PNMA1 expression correlates with poor prognosis, aggressive phenotypes, and larger tumors. PNMA1 represents a promising therapeutic target for tyrosine kinase inhibitors and pathway-based interventions across cancers.